This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cytokinetics, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: John Mao - Innovator in ALS Therapy
Introduction
John Mao is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of Amyotrophic Lateral Sclerosis (ALS). His innovative approach combines existing therapies to enhance patient outcomes.
Latest Patents
John Mao holds a patent for a method of treating ALS, which involves administering a therapeutically effective amount of riluzole and CK-2017357. This patent outlines various methods to optimize the treatment, including reducing variability in riluzole exposure, decreasing the total daily dose, and increasing the drug's half-life. His work aims to improve the overall efficacy and safety of ALS treatments.
Career Highlights
Mao is currently associated with Cytokinetics, Inc., where he continues to develop innovative therapies. His dedication to advancing medical science is evident in his research and patent contributions. With 1 patent to his name, he is recognized for his commitment to improving patient care.
Collaborations
Some of his notable coworkers include Jesse Cedarbaum and Fady Malik, who share his vision of enhancing ALS treatment options. Their collaborative efforts contribute to the ongoing research and development in this critical area of medicine.
Conclusion
John Mao's work in ALS therapy exemplifies the impact of innovation in healthcare. His contributions are paving the way for more effective treatments and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile